Authors: KAUFMANN IM JONAT W VONMINCKWITZ G SCHMID H KLEINE W MELCHERT F ULMER MU STOSIEK U TRAMS G BALZER J CAFFIER H

Citation: Im. Kaufmann et al., COMPARISON OF DOXORUBICIN CYCLOPHOSPHAMIDE VERSUS DOXORUBICIN/CYCLOPHOSPHAMIDE/TAMOXIFEN AND CMF-CHEMOTHERAPY VERSUS TAMOXIFEN IN NODE-POSITIVE BREAST-CANCER - AN UPDATE OF THE GERMAN ADJUVANT BREAST-CANCER GROUP (GABG) TRIAL/, European journal of cancer, 34, 1998, pp. 82-82

Authors: VONMINCKWITZ G KAUFMANN M SCHMID H KLEINE W BRUNNERT K ULMER MU STOSIEK U MAHLKE M MEHRPOHL HG NEISES M BALTZER J

Citation: G. Vonminckwitz et al., RANDOMIZED TRIALS TO ASSESS THE EFFECTIVITY OF TAMOXIFEN AS ADJUVANT TREATMENT IN NODE-NEGATIVE AND RECEPTOR-POSITIVE BREAST-CANCER - THE HEIDELBERG-II AND GABG-II TRIALS, European journal of cancer, 34, 1998, pp. 96-96

Authors: HAMANN U HANER M STOSIEK U BASTERT G SCOTT RJ

Citation: U. Hamann et al., LOW-FREQUENCY OF BRCA1 GERMLINE MUTATIONS IN 45 GERMAN BREAST OVARIANCANCER FAMILIES/, Journal of Medical Genetics, 34(11), 1997, pp. 884-888

Authors: RAUSCHECKER HF SAUER R SCHAUER A SCHUMACHER M HAASE W BECHT I DORNOFF W BRAUN M FINKENWERDER H SCHULTEOVERBERG G NEUMANN R VERING A GEIER G UNBEHAUN V STAHLKUSCHEL S SAUER U MOORTHI K GATZEMEIER W BOHM C EKUE S STOSIEK U STAIGER HF SELCH A KIEHN J FRICKE B SCHARSICH M GOBEL R OTT G KIENLE B KIFFNER E OVERMANN E LENTZEN M SIEKMANN U MEUSEL P FISCHER M GRILLO M HEIDEGGER H SALZ HP BOOTHMAN G BREITBACH GP MINK D BERGAUER O KURZ E BEYERLE C ZIEGER W EBERL M BRUNNERT K OLSCHEWSKI M SAUERBRIE W SEEGENSCHMIEDT MH SCHMOOR C

Citation: Hf. Rauschecker et al., THERAPY OF SMALL BREAST-CANCER - 4-YEAR RESULTS OF A PROSPECTIVE NONRANDOMIZED STUDY, Breast cancer research and treatment, 34(1), 1995, pp. 1-13